GALNF Stock Chart & Stats
$114.79
--
Market closed
$114.79
--
Day’s Range― - ―
52-Week Range$98.11 - $139.91
Previous CloseN/A
VolumeN/A
Average Volume (3M)24.00
Market Cap
$5.37B
Enterprise Value$5.15B
Total Cash (Recent Filing)$115.51M
Total Debt (Recent Filing)$1.06B
Price to Earnings (P/E)23.8
Beta0.04
Next Earnings
Aug 06, 2026EPS Estimate
2.41Next Dividend Ex-DateN/A
Dividend Yield3.33%
Share Statistics
EPS (TTM)3.63
Shares Outstanding50,000,000
10 Day Avg. Volume0
30 Day Avg. Volume24
Financial Highlights & Ratios
PEG Ratio-24.69
Price to Book (P/B)3.29
Price to Sales (P/S)1.18
P/FCF Ratio17.88
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue1.25
Enterprise Value/Gross Profit12.30
Enterprise Value/Ebitda14.84
Forecast
1Y Price Target
$104.97Price Target Upside-8.56% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)4.86
Revenue Forecast (FY)$5.42B
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent free-cash-flow (272M in 2025, ~91% of net income) indicates strong cash conversion. Durable cash generation supports reinvestment in logistics and retail, funds dividends and debt service, and reduces reliance on external financing over the medium term.
Integrated Distribution And Retail NetworkGalenica's integrated wholesale logistics and national pharmacy retail network creates scale advantages and recurring demand. Structural platform and distribution infrastructure raise switching costs, improve service capture and support stable revenues across business cycles.
Revenue Rebound With Stable MarginsRevenue returning to growth (4.14B in 2025) alongside steady operating margins (~5.4% EBIT) signals operational resilience. A rebound with margin stability supports sustainable earnings capacity and improves capacity for medium-term strategic investments.
Bears Say
Rising LeverageLeverage increased materially to a debt-to-equity of ~0.72 with total debt at 1.06B, up from ~0.16 in 2023. Higher debt reduces financial flexibility, raises interest and refinancing risk, and makes the firm more vulnerable to earnings or rate shocks over the medium term.
Gross Margin VolatilityNotable gross-margin swings (a pronounced uptick in 2024 versus other years) point to exposure to product-mix shifts or cost-of-sales variability. Persistent margin volatility undermines earnings visibility and can compress operating profitability if adverse trends persist.
Uneven Free Cash Flow GrowthAlthough FCF is positive, growth has been uneven with declines in 2022, 2023 and 2025, reflecting working-capital swings. This variability can limit predictable funding for capex, dividends or debt paydown and complicate medium-term financial planning.
Galenica AG News
GALNF FAQ
What was Galenica AG’s price range in the past 12 months?
Galenica AG lowest stock price was $98.11 and its highest was $139.91 in the past 12 months.
What is Galenica AG’s market cap?
Galenica AG’s market cap is $5.37B.
When is Galenica AG’s upcoming earnings report date?
Galenica AG’s upcoming earnings report date is Aug 06, 2026 which is in 32 days.
How were Galenica AG’s earnings last quarter?
Galenica AG released its earnings results on Mar 10, 2026. The company reported $2.326 earnings per share for the quarter, missing the consensus estimate of $2.484 by -$0.159.
Is Galenica AG overvalued?
According to Wall Street analysts Galenica AG’s price is currently Overvalued.
Does Galenica AG pay dividends?
Galenica AG pays a Annually dividend of $1.593 which represents an annual dividend yield of 3.33%. See more information on Galenica AG dividends here
What is Galenica AG’s EPS estimate?
Galenica AG’s EPS estimate is 2.41.
How many shares outstanding does Galenica AG have?
Galenica AG has 50,000,000 shares outstanding.
What happened to Galenica AG’s price movement after its last earnings report?
Galenica AG reported an EPS of $2.326 in its last earnings report, missing expectations of $2.484. Following the earnings report the stock price went up 0.025%.
Which hedge fund is a major shareholder of Galenica AG?
Currently, no hedge funds are holding shares in GALNF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Galenica AG
Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
GALNF Stock 12 Month Forecast
Average Price Target
$104.97
▼(-8.56% Downside)
Ownership Overview
―
Insiders
6.29% Mutual Funds
― Other Institutional Investors
84.37% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---